Algorithmic Assessment of Missense Mutation Severity in the Von-Hippel Lindau Protein

作者: Francisco R. Fields , Niraja Suresh , Morgan Hiller , Stefan D. Freed , Kasturi Haldar

DOI: 10.1101/2020.05.20.106021

关键词:

摘要: Von Hippel-Lindau disease (VHL) is an autosomal dominant rare that causes the formation of angiogenic tumors. When functional, pVHL acts as E3 ubiquitin ligase negatively regulates hypoxia inducible factor (HIF). Genetic mutations perturb structure result in dysregulation HIF, causing a wide array tumor pathologies including retinal angioma, pheochromocytoma, central nervous system hemangioblastoma, and clear cell renal carcinoma. These VHL-related cancers occur throughout lifetime patient, requiring frequent intervention procedures, such surgery, to remove Although VHL classified (1 39,000 1 91,000 affected) there large heterogeneity genetic listed for observed pathologies. Understanding how these specific correlate with myriad could provide clinicians insight into potential severity onset disease. Using set 285 ClinVar VHL, we developed multiparametric scoring algorithm evaluate overall clinical missense pVHL. The were assessed according eight weighted parameters comprehensive evaluation protein misfolding malfunction. Higher mutation scores strongly associated pathogenicity. Our approach establishes novel  silico method by which VHL-specific can be their effect on biophysical functions protein.

参考文章(62)
Richard C Lewontin, Genotype and Phenotype International Encyclopedia of the Social & Behavioral Sciences. pp. 42- 45 ,(2015) , 10.1016/B978-0-08-097086-8.81008-9
Greet Vanhoof, Filip Goossens, Ingrid De Meester, Dirk Hendriks, Simon Scharpé, Proline motifs in peptides and their biological processing. The FASEB Journal. ,vol. 9, pp. 736- 744 ,(1995) , 10.1096/FASEBJ.9.9.7601338
Patrick H. Maxwell, Michael S. Wiesener, Gin-Wen Chang, Steven C. Clifford, Emma C. Vaux, Matthew E. Cockman, Charles C. Wykoff, Christopher W. Pugh, Eamonn R. Maher, Peter J. Ratcliffe, The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature. ,vol. 399, pp. 271- 275 ,(1999) , 10.1038/20459
J. Lisztwan, G. Imbert, C. Wirbelauer, M. Gstaiger, W. Krek, The von Hippel–Lindau tumor suppressor protein is a component of an E3 ubiquitin–protein ligase activity Genes & Development. ,vol. 13, pp. 1822- 1833 ,(1999) , 10.1101/GAD.13.14.1822
Kai Ren Ong, Emma R. Woodward, Pip Killick, Caron Lim, Fiona Macdonald, Eamonn R. Maher, Genotype-phenotype correlations in von Hippel-Lindau disease. Human Mutation. ,vol. 28, pp. 143- 149 ,(2007) , 10.1002/HUMU.20385
M.M. Gromiha, Prediction of protein stability upon point mutations Biochemical Society Transactions. ,vol. 35, pp. 1569- 1573 ,(2007) , 10.1042/BST0351569
Catherine Gallou, Dominique Chauveau, Stéphane Richard, Dominique Joly, Sophie Giraud, Sylviane Olschwang, Natacha Martin, Céline Saquet, Yves Chrétien, Arnaud Méjean, Jean-Michel Correas, Gérard Benoît, Pierre Colombeau, Jean-Pierre Grünfeld, Claudine Junien, Christophe Béroud, Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions. Human Mutation. ,vol. 24, pp. 215- 224 ,(2004) , 10.1002/HUMU.20082
O. Iliopoulos, M. Ohh, W. G. Kaelin, pVHL19 is a biologically active product of the von Hippel–Lindau gene arising from internal translation initiation Proceedings of the National Academy of Sciences of the United States of America. ,vol. 95, pp. 11661- 11666 ,(1998) , 10.1073/PNAS.95.20.11661
Ana Martins Metelo, Haley R. Noonan, Xiang Li, Youngnam Jin, Rania Baker, Lee Kamentsky, Yiyun Zhang, Ellen van Rooijen, Jordan Shin, Anne E. Carpenter, Jing-Ruey Yeh, Randall T. Peterson, Othon Iliopoulos, Pharmacological HIF2α inhibition improves VHL disease–associated phenotypes in zebrafish model Journal of Clinical Investigation. ,vol. 125, pp. 1987- 1997 ,(2015) , 10.1172/JCI73665